Prof Wildes meets with ecancertv at SIOG 2016 to discuss treating multiple myeloma in elderly patients.
She describes how an aggressive course of treatment is not always the best regimen, especially in the geriatric setting, and references clinical trials establishing maintenance therapy as more tolerable overall.
Prof Wildes considers how this might inform treatment guidelines, and the place of immunotherapy in future care programs.
